p37 from Mycoplasma hyorhinis promotes cancer cell invasiveness and metastasis through activation of MMP-2 and followed by phosphorylation of EGFR

Molecular Cancer Therapeutics

Volumn 7, Issue 3, 2008, Pages 530-537

  Gong, Manman ^a   Meng, Lin ^a   Jiang, Beihai ^a   Zhang, Jianzhi ^a   Yang, Hua ^a   Wu, Jian ^a   Shou, Chengchao ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; GELATINASE A; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN P37; VIRULENCE FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; CANCER CELL; CANCER INVASION; CARCINOGENESIS; CARCINOGENICITY; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG METASTASIS; MELANOMA CELL; METASTASIS; MOUSE; MYCOPLASMA HYORHINIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STOMACH CANCER;

BACTERIAL PROTEINS; CELL LINE, TUMOR; ENZYME ACTIVATION; HUMANS; MATRIX METALLOPROTEINASE 2; MYCOPLASMA HYORHINIS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 41649110830     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-07-2191     Document Type: Article

References (44)

1. Loo VG, Richardson S, Quinn P. Isolation of Mycoplasma pneumoniae from pleural fluid. Diagn Microbiol Infect Dis 1991;14:443-5.
2. Taylor-Robinson D. Genital Mycoplasma infections. Clin Lab Med 1989;9:501-23.
3. Paton GR, Jacobs JP, Perkins FT. Chromosome changes in human diploid-cell cultures infected with Mycoplasma. Nature 1965;207:43-5.
4. Fogh J, Fogh H. Chromosome changes in PPLO-infected FL human amnion cells. Proc Soc Exp Biol Med 1965;119:233-8.
5. Macpherson I, Russell W. Transformations in hamster cells mediated by mycoplasmas. Nature 1966;210:1343-5.
6. Tsai S, Wear DJ, Shih JW, Lo SC. Mycoplasmas and oncogenesis: persistent infection and multistage malignant transformation. Proc Natl Acad Sci U S A 1995;92:10197-201.
7. Feng SH, Tsai S, Rodriguez J, Lo SC. Mycoplasmal infections prevent apoptosis and induce malignant transformation of interleukin-3-dependent 32D hematopoietic cells. Mol Cell Biol 1999;19:7995-8002.
8. Dudler R, Schmidhauser C, Parish RW, Wettenhall REH, Schmidt T. A Mycoplasma high-affinity transport system and the in vitro invasiveness of mouse sarcoma cells. EMBO J 1988;7:3963-70.
9. Gilson E, Alloing G, Schmidt T, et al. Evidence for a high affinity binding-protein dependent transport system in Gram-positive bacteria and in Mycoplasma. EMBO J 1988;7:3971-4.
10. Steinemann C, Fenner M, Binz H, Parish RW. Invasive behavior of mouse sarcoma cells is inhibited by blocking a 37,000-dalton plasma membrane glycoprotein with Fab fragments. Proc Natl Acad Sci U S A 1984;81:3747-50.
11. Schmidhauser C, Dudler R, Schmidt T, Parish RW. A mycoplasmal protein influences tumour cell invasiveness and contact inhibition in vitro. J Cell Sci 1990;95:499-506.
12. Ushio S, Iwaki K, Taniai M, et al. Metastasis-promoting activity of a novel molecule, Ag 243-5, derived from Mycoplasma, and the complete nucleotide sequence. Microbiol Immunol 1995;39:393-400.
13. Ketcham CM, Anai S, Reutzel R, et al. p37 induces tumor invasiveness. Mol Cancer Ther 2005;4:1031-8.
14. Ning JY, Huang S, Wu J, Meng L, Shou CC. Protein p37 of Mycoplasma hyorhinis induced secretion of TNF-α from human peripheral blood mononuclear cells. Chin Sci Bull 2003;48:658-62.
15. Ktta M, Ohmoto Y, Hirai Y, et al. Induction of cytokines in human peripheral blood mononuclear cells by mycoplasmas. Microbiol Immunol 1992;36:507-16.
16. Kostyal DA, Butler GH, Beezhold DH. Mycoplasma hyorhinis molecules that induce tumor necrosis factor a secretion by human monocytes. Infect Immun 1995;63:3858-63.
17. Liu WB, Zhang JZ, Jiang BH, et al. Lipoprotein p37 from Mycoplasma hyorhinis inhibiting mammalian cell adhesion. J Biomed Sci 2006;13:323-31.
18. Su H, Jiyou L, Jian W, Lin M, Chengchao S. Mycoplasma infections in different carcinomas. World J Gastroenterol 2001;7:266-9.
19. Gong MM, Meng L, Liu WB, Zhang JZ, Shou CC. Establishment of stable and regulable 293 cell line expressing Mycoplasma hyorhinis protein p37. J Peking Univ 2005;37:575-578.
20. Wang QQ, Jiang P, Li JM, Tang RZ, Chen XM. A lung cancer associated antigen purified by the wheat germ lectin-Sepharose-6MB. Immunol J 2000;16:87-91.
21. Frederique S, Sandra D, Veronique VF, et al. Expression of neurotensin and NT1 receptor in human breast cancer: a potential role in tumor progression. Cancer Res 2006;66:6243-9.
22. Du CW, Wen BG, Li DR, et al. Arsenic trioxide reduces the invasive and metastatic properties of nasopharyngeal carcinoma cells in vitro. Braz J Med Biol Res 2006;39:677-85.
23. Park MJ, Kim MS, Park IC, et al. PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation. Cancer Res 2002;62:6318-22.
24. Mehlen P, Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer 2006;6:449-58.
25. Suzuki M, Raab G, Moses MA, Fernadez CA, Klagsburn M. Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site. J Biol Chem 1997;272:31730-37.
26. Ilantzis C, Thomson DM, Michaelidou A, Benchimol S, Stanners CP. Identification of a human cancer related organ-specific neoantigen. Microbiol Immunol 1993;37:119-28.
27. Steinmann C, Fenner M, Parish RW, Binz H. Studies of the invasiveness of the chemically induced mouse sarcoma FS9. I. Monoclonal antibodies to a 37,000 dalton membrane glycoprotein inhibit invasion of fibroblasts in vitro. Int J Cancer 1984;34:407-14.
28. Peek RM, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002;2:28-37.
29. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7.
30. Afzal S, Lalani EN, Poulsom R, et al. MT1-MMP and MMP-2 mRNA expression in human ovarian tumors: possible implications for the role of desmoplastic fibroblasts. Hum Pathol 1998;29:155-65.
31. Haro H, Crawford HC, Fingleton B, et al. Matrix metalloproteinase-7- dependent release of tumor necrosis factor-α in a model of herniated disc resorption. J Clin Invest 2000;105:143-50.
32. Levi E, Fridman R, Miao HQ, et al. Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. Proc Natl Acad Sci U S A 1996;93:7069-74.
33. Gearing AJ, Beckett P, Christodoulou M, et al. Processing of tumour necrosis factor-a precursor by metalloproteinases. Nature 1994;370:555-7.
34. McGeehan MG, Becherer JD, Bast RCJ, et al. Regulation of tumour necrosis factor-a processing by a metalloproteinase inhibitor. Nature 1994;370:558-60.
35. Manes S, Mira E, Barbacid MM, et al. Identification of insulin-like growth factor-binding protein-1 as a potential physiological substrate for human stromelysin-3. J Biol Chem 1997;272:25706-12.
36. Ravanti L, Kahari VM. Matrix metalloproteinases in wound repair [review]. Int J Mol Med 2000;6:391-407.
37. Mattila E, Pellinen T, Nevo J, et al. Negative regulation of EGFR signaling through integrin-a1h1-mediated activation of protein tyrosine phosphatase TCPTP. Nat Cell Bio 2005;7:78-85.
38. Codony-Servat J, Albanell J, Lopez-Talavera JC, Arribas J, Baselga J. Cleavage of the HER2 ectodomain is a pervanadate-activable process that is inhibited by the tissue inhibitor of metalloproteases-1 in breast cancer cells. Cancer Res 1999;59:1196-201.
39. Vecchi M, Rudolph-Owen LA, Brown CL, Dempsey PJ, Carpenter G. Tyrosine phosphorylation and proteolysis. Pervanadate-induced, metalloprotease-dependent cleavage of the ErbB-4 receptor and amphiregulin. J Biol Chem 1998;273:20589-95.
40. Prenzel N, Zwick E, Daub H, et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHBEGF. Nature 1999;402:884-8.
41. Zhang B, Tsai S, Shih J, Wear DJ, Lo SC. Absence of mycoplasmal gene in malignant mammalian cells transformed by chronic persistent infection of mycoplasmas. Proc Soc Exp Biol Med 1998;218:82-8.
42. Jones JL, Walker RA. Control of matrix metalloproteinase activity in cancer. J Pathol 1997;183:377-9.
43. Murphy G, Stanton H, Cowell S, et al. Mechanisms for pro matrix metalloproteinase activation. APMIS 1999;107:38-44.
44. Han YP, Tuan TL, Wu HY, Hughes M, Garner WL. TNF-α stimulates activation of pro-MMP2 in human skin through NF-κB mediated induction of MT1-MMP. J Cell Sci 2000;114:131-9.